ArticleNature medicine2017

A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.

Sumeet A Khetarpal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.